# Longitudinal Early-onset Alzheimer's Disease Study Protocol

> **NCT03507257** · — · RECRUITING · sponsor: **Indiana University** · enrollment: 850 (estimated)

## Conditions studied

- Early Onset Alzheimer Disease
- Alzheimer Disease
- Mild Cognitive Impairment

## Interventions

- **DRUG:** Flortaucipir
- **DRUG:** Florbetaben
- **DRUG:** Fluorodeoxyglucose

## Key facts

- **NCT ID:** NCT03507257
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-04-30
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 850 (ESTIMATED)
- **Last updated:** 2026-02-18

## Collaborators

- Alzheimer's Therapeutic Research Institute
- National Institute on Aging (NIA)
- Alzheimer's Association

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03507257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03507257, "Longitudinal Early-onset Alzheimer's Disease Study Protocol". Retrieved via AI Analytics 2026-05-18 from https://api.ai-analytics.org/clinical/NCT03507257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*